Trial intelligence / Profile preview

PRP Infusion Before Thawed Embryo Transfer in Repeated Implantation Failure

NCT03734042Phase 4Completed

Sponsor
Tanta University
Start
Dec 2018
Primary completion
Oct 2021
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Phase 4, randomised trial of platelet-rich plasma injection in Repeated Implantation Failure (RIF) (2 arms), sponsored by Tanta University. Primary endpoints: Endometrial thickness at 8 days and Pregnancy rate at 15 days. Started Dec 2018; status: completed.

02

Drugs

platelet-rich plasma injection
03

Conditions

Repeated Implantation Failure (RIF)

Beyond the preview

Go deeper on NCT03734042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03734042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call